Skip to main content

This job has expired

You will need to login before you can apply for a job.

Executive/VP Medical Director, Clinical Development (MD required)

AnaptysBio, Inc.
San Diego, CA
Start date
Feb 2, 2024

View more

Job Details

Job Type Full-time

Position Summary

We continue to expand our team. This position will be primarily responsible for providing strategic and scientific leadership for the clinical programs as well as setting the clinical strategy while working alongside of the VP, Clinical Development and other members of the team.  This role will lead the design, plan and execution of clinical trials, and running of programs focused on assigned therapeutic areas, in accordance with applicable regulatory and quality standards, and company timelines and budgets.  Activities are geared toward ensuring that all clinical activities related to clinical trials are managed effectively in support of regulatory submissions and subsequent approval. This role includes being more broadly a thought partner with the leadership team for rare disease development strategies. 

Essential Functions

  • Lead the development and execution of clinical plans to drive programs through clinical studies. Identify needs, contingencies and operational plans, while also ensuring strategic positioning is in line with company goals.
  • Serves as the top representative for clinical development/medical strategy areas both internal and external facing. 
  • In close collaboration with all involved line functions such as operations, regulatory etc., of designated clinical studies.
  • Provide strategic input on new indications and/or opportunities for antibodies already in development as well as for novel antibodies entering the clinic
  • Work closely with the discovery team helping in the identification of novel targets
  • Write and/or facilitate the writing of clinical project management documents such as project scope definition documents, project training materials, monitoring plans and monitoring tools, study protocols, safety plans, recruitment plans and closeout plans, etc.
  • Coordinate/execute  operational aspects of assigned clinical studies (including identification, selection, qualification and management of clinical investigators and third party vendors, test article release to sites, site monitoring activities, ongoing review of key study data, etc.).
  • Review and approve monitoring reports and follow-up letters prepared by the project CRAs for assigned studies.
  • Plan and review the analysis of clinical data and determine the ultimate interpretation of results.
  • Ensure the assigned trials are “audit ready” at all times (project team training records, current regulatory documents, appropriate IRB approvals, monitoring tools required for the trial).  Ensure that any audit observations are addressed appropriately and in a timely manner.
  • Develop and maintain project schedules, with key metrics, for clinical projects to ensure optimal study management.  Identify and resolve issues that impact project scope, resources. or timelines and communicate to senior management.
  • Develop and monitor overall clinical development budget for assigned projects; effectively manage resources, funding and expenses. Assist with tracking and forecasting resource capacity and utilization to ensure that required clinical development resources are available when needed and optimally utilized.
  • Provide therapy area medical and scientific expertise to study teams and key stakeholders.
  • Anticipate trends in medicine and industry that may/will have an impact on the clinical/commercial viability of products and factors into planning.
  • Serve as principal medical monitor overseeing all aspects of the safety monitoring in the clinical development programs.
  • Prepare clinical sections of regulatory documents such as investigator brochures, INDs, NDAs, BLAs, background packages for FDA meetings, etc. Provide medical review and approval of regulatory documents pertaining to the work of the clinical team.
  • Cultivate and nurture strong collaborations with key opinion leaders, Investigators, research centers and corporate partners.
  • Collaborate with Business Development, Senior R&D and Commercial leadership to identify, recommend and develop strategic alliances, partnership and licensing opportunities requiring due diligence work and strategic input.
  • Engage and inspire the project/clinical development team through communicating the strategic vision and the operational plan to achieve the vision.


Education and Experience: 

  • MD and US medical license, with 13+ years of clinical drug development related experience in the research and development of novel biologics, particularly within the field of inflammation.
  • Expertise in RA or related diseases preferred
  • Expertise in preclinical, translational and early clinical development within the field of inflammation
  • Extensive academic and pharma collaborative network. History of personal interaction with thought leaders in the      inflammation field.
  • Track record of program leadership and achievement of goals and deliverables, of effective collaboration,      effectiveness in team settings, and team leadership
  • Experience with Microsoft Word, Excel, PowerPoint, Outlook, Adobe, and Internet Explorer.

Knowledge Requirements: 

  • Firm understanding of the mechanistic basis of human inflammatory disorders
  • Thorough understanding of clinical protocols and regulatory processes.
  • Excellent understanding of the drug development process
  • Thorough knowledge of FDA requirements, Good Clinical Practices, and pharmaceutical clinical development. 
  • Demonstrated success establishing, communicating and driving a vision and strategy for a therapeutic area/product, and develop an integrated plan of action including milestones and endpoints and ensure executional excellence.
  • Viewed as a leader within the therapeutic area/disease state and considered a scientific contributor and innovator within internal and external spheres of influence.
  • The ability to think globally, strategically and innovatively about the future of the disease state and company’s therapeutic agents and possess a solid understanding of the pharmaceutical industry, company competition and commercial side of      business, including Marketing and Sales, Market Access, Pricing/Reimbursement, Business Development, Medical Affairs and Supply Chain.


Physical Demands

The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.

While performing the duties of this job, the employee is regularly required to sit and talk or hear. The employee frequently is required to use hands to finger, handle, or feel. The employee is occasionally required to stand, walk, and reach with hands and arms. The employee must occasionally lift and/or move up to 10 pounds. Specific vision abilities required by this job include close vision and ability to adjust focus in order to read.

Work Environment

The work environment characteristics are representative of those an employee encounters while performing the essential functions of this job, typically in an office environment. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.

The noise level in the work environment is usually moderate.

May be required to travel by plane domestically and internationally about 15% of the time

All qualified applicants will receive consideration for employment without regard to race, color, sex, sexual orientation, gender identity, religion, national origin, disability, veteran status, age, marital status, pregnancy, genetic information, or other legally protected status.

Salary Description $196k-$310k, 25% bonus, 10% 401k, Options & RSU


AnaptysBio is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics. We are developing immune cell modulators, including two checkpoint agonists in clinical-stage development, for autoimmune and inflammatory disease: rosnilimab, our PD-1 agonist program in a Phase 2 trial for the treatment of moderate-to-severe rheumatoid arthritis; and ANB032, our BTLA agonist program, currently in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis. Our preclinical immune cell modulator portfolio includes ANB033, an anti-CD122 antagonist antibody for the treatment of autoimmune and inflammatory diseases. In addition, AnaptysBio has developed two cytokine antagonists available for out-licensing: imsidolimab, an anti-IL-36R antagonist, in Phase 3 for the treatment of generalized pustular psoriasis, or GPP, and etokimab, an anti-IL-33 antagonist for the treatment of respiratory disorders that is Phase 2/3 ready. AnaptysBio has also discovered multiple therapeutic antibodies licensed to GSK in a financial collaboration for immune-oncology, including an anti-PD-1 antagonist antibody (Jemperli (dostarlimab-gxly)), an anti-TIM-3 antagonist antibody (cobolimab, GSK4069889) and an anti-LAG-3 antagonist antibody (GSK4074386).

Our corporate vision is to transform patient health by delivering innovative immunology therapeutics. Find out more about us by following us on Twitter.




Company info
10770 Wateridge Circle
Suite 210
San Diego

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert